Slavik Osipchuk is a Boise, Idaho based nurse practitioner. Active license number of Slavik Osipchuk is 62202 in Idaho. His current practice location is 987 S Allante Pl, Boise. Patients can reach him at 208-947-7246 or can fax him at 208-297-7772. Slavik Osipchuk is NP and his NPI number (Unique professional ID assigned by NPPES) is 1164043162. Slavik Osipchuk has completed additional training beyond basic nursing education and provides primary health care services in accordance with state nurse practice laws or statutes. NPs are trained to assess patient needs, order and interpret diagnostic and laboratory tests, diagnose disease, formulate and prescribe medications and treatment plans.
Complete Profile:
Slavik Osipchuk speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1164043162
NPI Enumeration Date:
30 Apr, 2020
NPI Last Update On:
14 Jan, 2025
Medical Licenses:
NPs can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Slavik Osipchuk are as mentioned below.
License Number
Specialization
State
Status
62202
Idaho
Primary
62202
Nurse Practitioner
Idaho
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Slavik Osipchuk 987 S Allante Pl, Boise, Idaho
Zip:
83709-1612
Phone Number:
208-947-7246
Fax Number:
208-297-7772
Patients can reach Slavik Osipchuk at 987 S Allante Pl, Boise, Idaho or can call to book an appointment on 208-947-7246.
Comments/ Reviews:
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 June, 2025.